Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (EU) 2015/1221

xx xxx 24. čxxxxxxx 2015,

xxxx&xxxxxx;x xx xxx účely xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx pokroku xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; a balení x&xxxxxx;xxx a směsí

(Xxxx s x&xxxxxx;xxxxxx xxx XXX)

XXXXXXX&Xxxxxx; XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; unie,

x&xxxx;xxxxxxx xx nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 xx xxx 16. prosince 2008 x&xxxx;xxxxxxxxxxx, označování a balení x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx xx čx.&xxxx;37 xxxx.&xxxx;5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

xxxxxxxx k těmto xůxxxůx:

(1)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX nařízení (XX) č.&xxxx;1272/2008 xxxxxxxx dva xxxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; stanovených x&xxxx;č&xxxxxx;xxxxx 2 xž 5 xř&xxxxxx;xxxx X&xxxx;xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008. V tabulce 3.2 xx uveden xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx na x&xxxxxx;xxxxě kritérií xxxxxxxx&xxxxxx;xx x&xxxx;xř&xxxxxx;xxxx XX xxěxxxxx Xxxx 67/548/EHS (2).

(2)

Evropské agentuře xxx chemické x&xxxxxx;xxx (XXXX) xxxx x&xxxx;xxxxxxx x&xxxx;čx&xxxxxx;xxxx&xxxx;37 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 předloženy x&xxxxxx;xxxx xx xxx&xxxxxx; nebo xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx. Xx základě xxxxxxxxxx x&xxxx;xěxxx x&xxxxxx;xxxůx, xxxx&xxxxxx; xxxxx X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; rizik (RAC) xůxxx&xxxxxx;x&xxxxxx; x&xxxx;x&xxxxxx;xxx Xxxxxxx&xxxxxx; xxxxxxxx xxx xxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxxž i připomínek x&xxxxxx;čxxxxěx&xxxxxx;xx xxxxx, je xxxxx&xxxxxx; xxěxxx přílohy XX xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx; xxx&xxxxxx;xx čx xxxxxxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx a označení xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(3)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx „kyselina xxxxčx&xxxxxx; &xxxxxx; %&xxxxx; (č.&xxxx;XX: 231-714-2), xxxx xxx&xxxxxx; x&xxxx;xxxxxxxxx xxx&xxxxxx; vědecké &xxxxxx;xxxx xxx xř&xxxxxx;xx xxxxxxxčxxxxx &xxxxx;xxxxx&xxxxxx; xxxxxxxx&xxxxx;, xxxx&xxxxxx; xxxxxčxx&xxxxxx;, že xxxxxxxxxxx xxx xxxx xř&xxxxxx;xx nebezpečnosti xxxxxxčxxxx&xxxxxx; xx xxxxxxxxxx výboru XXX, xxž xx xxxx&xxxxxx;x&xxxxxx; xx xxxx&xxxxxx;&xxxxxx;xx &xxxxxx;xxx&xxxxxx;xx, xx xxxxxxxx x&xxxxxx;x přiměřená. Tato xř&xxxxxx;xx xxxxxxxčxxxxx xx xxxxx xxxěxx x&xxxxxx;x xxřxxxxx do přílohy XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxxx x&xxxxxx;xxx XXX nevydá xxxxxxxxxx x&xxxx;xxx&xxxxxx;x informacím, zatímco x&xxxxxx;xxxxx xxxxxx&xxxxxx; třídy xxxxxxxčxxxxx xxxxžxx&xxxxxx; x&xxxx;xxxxxxxx&xxxxxx;x xxxxxxxxxx x&xxxxxx;xxxx XXX xx xxřxxxxx x&xxxxxx;x xěxx.

(4)

Xxxxx xxx o látku &xxxxx;xxxxx, xxxxxxx-, xxxxěxxxx&xxxxxx;&xxxxx; (č.&xxxx;XX: 310-154-3), x&xxxxxx;xxx XXX xxxxxxxx&xxxxxx;x&xxxxxx; xxx&xxxxxx; xxxxxxxxxx xxxxxxě xxxxxxxxx&xxxxxx;xx xxxxxxxxxčx&xxxxxx;xx xxxxxů, xxxx&xxxxxx; xx použijí xxx xř&xxxxxx;xx xxxxxxxčxxxxx &xxxxx;xxxxxx&xxxxxx; xxx xxxxxxxxxx&xxxxx;. Tato xř&xxxxxx;xx xxxxxxxčxxxxx by xxxxx xxxěxx být xxřxxxxx xx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxxx toto xxxxxxxxxx xxxxxx dokončeno.

(5)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; xx nemělo x&xxxxxx;x xxžxxxx&xxxxxx;xx xxxxx, xxxxxxž xxxxxxxxx&xxxxxx; xxxxx xxxřxxxxxx xxčxx&xxxxxx; čxxxx&xxxxxx; xxxxx&xxxxxx; xx xx, aby xřxxxůxxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x x&xxxx;xxxxxxx stávající x&xxxxxx;xxxx. Xxxxě xxxx xxxxx xxxřxxxxxx určité čxxxx&xxxxxx; xxxxx&xxxxxx; x&xxxx;xx xx, xxx mohli xxxxxx xxxxxxxxxx xxxxxxxxxx, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; z nových xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx xxxxxx&xxxxxx; xxx xxxxxxxxxx, kategorií 1&xxxx;X x&xxxx;1X (xxxxxxx 3.1) x&xxxx;xxxxxxxx&xxxxxx; 1 x&xxxx;2 (xxxxxxx&xxxx;3.2) nebo xxxx xxxxxx xxxxxx&xxxxxx; xxx xxxx&xxxxxx; xxxxxxxxx x&xxxx;xxžxxxx&xxxxxx; xxxxxxx dlouhodobé xxxř&xxxxxx;xxxx&xxxxxx; &xxxxxx;čxxxx xx xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, zejména xxx povinnosti xxxxxxxx&xxxxxx; x&xxxx;čx&xxxxxx;xxx&xxxx;23 nařízení Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1907/2006 (3).

(6)

X&xxxx;xxxxxxx s přechodnými ustanoveními xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xxxx&xxxxxx; xxxžňxx&xxxxxx; dobrovolně xxxž&xxxxxx;x xxx&xxxxxx; ustanovení xř&xxxxxx;xx, xx xxxxxxxxx&xxxxxx; xěxx x&xxxxxx;x možnost xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxxxxxxxxě xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; xřxx xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(7)

Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x&xxxx;xxxxxxx se xxxxxxxxxxx x&xxxxxx;xxxx zřízeného xxxxx čx&xxxxxx;xxx&xxxx;133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX XXXX NAŘÍZENÍ:

Čx&xxxxxx;xxx&xxxx;1

Xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx xěx&xxxxxx; x&xxxx;xxxxxxx x&xxxx;xř&xxxxxx;xxxxx xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

Čx&xxxxxx;xxx&xxxx;2

Xxxxxxxě od čl. 3 xxxx.&xxxx;2 lze xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx stanovené v příloze xxxxxx xxř&xxxxxx;xxx&xxxxxx; xxxž&xxxxxx;x xřxx datem xxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;3 odst. 2.

Čx&xxxxxx;xxx&xxxx;3

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; xxxx.

2.   Článek 1 xx xxx x&xxxxxx;xxx x&xxxx;xxěxx xxxžxxx xxx xxx 1. xxxxx 2017.

Toto xxxxxxxx xx xxxxxxx v celém rozsahu x&xxxx;xxxxx použitelné xx xxxxx xxxxxxxxx státech.

V Bruselu xxx 24. xxxxxxxx 2015.

Xx Komisi

předseda

Jean-Claude JUNCKER


(1)&xxxx;&xxxx;Xx. xxxx. L 353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxx Xxxx 67/548/EHS xx xxx 27. xxxxxx 1967 x xxxxxxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxxxxxx, balení x xxxxxxxxxx xxxxxxxxxxxx xxxxx (Xx. xxxx.&xxxx;196, 16.8.1967, s. 1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (ES) x.&xxxx;1907/2006 xx dne 18. prosince 2006 x xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x xxxxxxxxx xxxxxxxxxx látek, o xxxxxxx Xxxxxxxx xxxxxxxx xxx xxxxxxxx látky, x xxxxx směrnice 1999/45/XX a x xxxxxxx xxxxxxxx Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (XX) x.&xxxx;1488/94, xxxxxxxx Rady 76/769/XXX x xxxxxxx Komise 91/155/XXX, 93/67/XXX, 93/105/ES x 2000/21/ESÚř. xxxx. X&xxxx;396, 30.12.2006, x.&xxxx;1.


XXXXXXX

Xxxx 3 přílohy XX nařízení (XX) x. 1272/2008 se xxxx xxxxx:

1)

Xxxxxxx 3.1 xx xxxx xxxxx:

x)

Xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X x&xxxx;613-149-00-7 xx xxxxxxxxx xxxxxx xxxxxxxxxxxxxx položkami:

Indexové xxxxx

Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx látek

Číslo XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx

Xxxx.

Xxxx xxxx a kategorií nebezpečnosti

Kódy xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx

007-004-00-1

xxxxxxxx xxxxxxx&xxxx;…&xxxx;%

231-714-2

7697-37-2

Xx. Xxx. 2

Skin Xxxx. 1&xxxx;X

X272

X314

XXX03

XXX05

Xxx

X272

X314

XXX071

Xxxx Corr. 1&xxxx;X; X314: X ≥ 20 %

Xxxx Corr. 1X; X314: 5 % ≤ X < 20 %

Xx. Xxx. 2; X272: X ≥&xxxx;99 %

Xx. Liq. 3; X272: 99 % &xx; X ≥ 65 %

X

015-003-00-2

xxxxxx xxxxxxxx; trikalcium xxxxxxxx

215-142-0

1305-99-3

Xxxxx-xxxxx. 1

Xxxxx Xxx. 2

Xxxxx Xxx. 3

Acute Xxx. 1

Xxx Xxx. 1

Xxxxxxx Acute 1

H260

H300

H311

H330

H318

H400

GHS02

GHS06

GHS05

GHS09

Dgr

H260

H300

H311

H330

H318

H400

EUH029

EUH032

M = 100

031-001-00-4

xxxxxxx galia

215-114-8

1303-00-0

Repr. 1X

Xxxx. 1X

XXXX XX 1

X360X

X350

X372 (xxxxxxx a krvetvorný systém)

GHS08

Dgr

H360F

H350

H372 (xxxxxxx x&xxxx;xxxxxxxxxx xxxxxx)

050-008-00-3

xxxxxxxxxxxxxxxx xxxxxxxxxx, s výjimkou xxxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxx jinde x&xxxx;xxxx xxxxxxx

Xxxx. 1X

Xxxxx Xxx. 3

Xxxxx Tox. 4*

XXXX XX 1

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X360XX

X301

X312

X372**

X315

X319

X400

X410

XXX08

XXX06

XXX09

Xxx

X360XX

X301

X312

X372**

X315

X319

X410

*

XXXX XX 1; X372: X ≥&xxxx;1 %

XXXX RE 2; X373: 0,25 % ≤ X &xx;&xxxx;1 %

Skin Xxxxx. 2; X315:X ≥&xxxx;1 %

Xxx Xxxxx. 2; X319:X ≥&xxxx;1 %

X&xxxx;= 10

X

1

603-102-00-9

1,2-xxxxxxxxxx

203-438-2

106-88-7

Xxxx. Liq. 2

Xxxx. 2

Xxxxx Xxx. 4*

Xxxxx Xxx. 4*

Xxxxx Xxx. 4*

XXXX SE 3

Skin Xxxxx. 2

Eye Irrit. 2

X225

X351

X302

X312

X332

X335

X315

X319

XXX02

XXX08

XXX07

Xxx

X225

X351

X302

X312

X332

X335

X315

X319

603-197-00-7

xxxxxxxxxxx (XXX); 1-(4-xxxxxxxxxx)-4,4-xxxxxxxx-3-(1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxx-3-xx

403-640-2

107534-96-3

Xxxx. 2

Xxxxx Xxx. 4

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X361x***

X302

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x***

X302

X410

X&xxxx;= 1

X&xxxx;= 10

606-054-00-7

xxxxxxxxxxx (XXX); 5-xxxxxxxxxxx-1,2-xxxxxx-4-xx-α,α,α-xxxxxxxx-2-xxxxx-x-xxxxxxxxxx

141112-29-0

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x***

X400

X410

XXX08

XXX09

Xxx

X361x***

X410

X&xxxx;= 10

X&xxxx;= 100

607-197-00-8

xxxxxxxx xxxxxxxx

203-931-2

112-05-0

Xxxx Xxxxx. 2

Eye Xxxxx. 2

Xxxxxxx Chronic 3

X315

X319

X412

XXX07

Xxx

X315

X319

X412

613-042-00-5

xxxxxxxx (ISO); 1-[2-allyloxy-2-(2,4-dichlorfenyl)ethyl]-1H-imidazol

252-615-0

35554-44-0

Carc. 2

Xxxxx Tox. 3

Xxxxx Xxx. 4

Xxx Xxx. 1

Xxxxxxx Xxxxxxx 1

X351

X301

X332

X318

X410

XXX08

XXX06

XXX05

XXX09

Xxx

X351

X301

X332

X318

X410

X&xxxx;= 10

613-057-00-7

xxxxxxxxx (XXX); 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx

216-474-9

1593-77-7

Xxxx. 2

XXXX RE 2

Xxxx Xxxx. 1X

Xxxx Sens. 1&xxxx;X

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X361x

X373 (xxxxx)

X314

X317

X400

X410

XXX08

XXX05

XXX07

XXX09

Xxx

X361x

X373 (xxxxx)

X314

X317

X410

XXX071

X&xxxx;= 1

X&xxxx;= 1

613-133-00-X

etridiazol (XXX); 5-ethoxy-3-trichlormethyl-1,2,4-thiadiazol

219-991-8

2593-15-9

Carc. 2

Xxxxx Xxx. 4

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X351

X302

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X302

X317

X410

X&xxxx;= 1

X&xxxx;= 1

613-149-00-7

xxxxxxxxx (ISO); 2-xxxx-xxxxx-5-[(4-xxxx-xxxxxxxxxxx)xxxxxxxx]-4-xxxxxxxxxxxxxx-3(2X)-xx

405-700-3

96489-71-3

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

M = 1&xxxx;000

X&xxxx;= 1&xxxx;000

x)

Xxxxxxxxxxx položky xx xxxxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx stanovených x&xxxx;xxxxxxx 3.1:

Xxxxxxxx xxxxx

Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx látek

Číslo XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx

Xxxx.

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

019-003-00-3

xxxxxx-(X,X)-xxxx-2,4-xxxxxxx

246-376-1

24634-61-5

Xxx Irrit. 2

X319

XXX07

Xxx

X319

604-092-00-9

xxxxx, xxxxxxx-, xxxxxxxxxx [1];

xxxxx, 2-xxxxxxx-, rozvětvený;

fenol, 3-xxxxxxx-, xxxxxxxxxx;

xxxxx, 4-xxxxxxx-, xxxxxxxxxx;

xxxxx, (xxxxxxxxxxxxx)xxxxxxxx&xxxx;[2]

310-154-3 [1]

121158-58-5 [1]

74499-35-7 [2]

Xxxx Corr. 1X

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X314

X400

X410

XXX05

XXX09

Xxx

X314

X410

X&xxxx;= 10

M = 10

606-148-00-8

karvon (XXX);

2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx; [1]

D-karvon; (5S)-2-methyl-5-(prop-1-en-2-yl)cyklohex-2-en-1-on; [2]

X-xxxxxx; (5X)-2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx [3]

202-759-5 [1]

218-827-2 [2]

229-352-5 [3]

99-49-0 [1]

2244-16-8 [2]

6485-40-1 [3]

Xxxx Xxxx. 1

X317

XXX07

Xxx

X317

606-149-00-3

xxxxxxxxxx (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx

335104-84-2

Xxxx. 2

XXXX RE 2

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X361x

X373 (xxx, xxxxxxx, xxxxx)

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X373 (xxx, xxxxxxx, xxxxx)

X317

X410

X&xxxx;= 100

X&xxxx;= 10

607-707-00-9

xxxxxxxxxx-X-xxxxx (XXX); xxxxx-(2X)-2-{4-[(6-xxxxx-1,3-xxxxxxxxxx-2-xx)xxx]xxxxxx}xxxxxxxxx

71283-80-2

XXXX XX 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X373 (xxxxxxx)

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X373 (xxxxxxx)

X317

X410

X&xxxx;= 1

X&xxxx;= 1

607-708-00-4

xxxxxxxx kyselina

204-677-5

124-07-2

Skin Xxxx. 1X

Xxxxxxx Xxxxxxx 3

X314

X412

XXX05

Xxx

X314

X412

607-709-00-X

xxxxxxxx xxxxxxxx

206-376-4

334-48-5

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Aquatic Xxxxxxx 3

X315

X319

X412

XXX07

Xxx

X315

X319

X412

607-710-00-5

1,2-xxxxxxxxxxxxxxxxxxx xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxx

271-093-5

68515-50-4

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX

607-711-00-0

xxxxxxxxxxxxx (ISO); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx

203313-25-1

Xxxx. 2

XXXX SE 3

Eye Xxxxx. 2

Skin Xxxx. 1&xxxx;X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X361xx

X335

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361xx

X335

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

607-712-00-6

xxxxxxxx-xxxxxx; 4-cyklododecyl-2,6-dimethylmorfolin-4-ium-acetát

250-778-2

31717-87-0

Repr. 2

XXXX XX 2

Xxxx Xxxx. 1X

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 1

H361d

H373 (játra)

H314

H317

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d

H373 (xxxxx)

X314

X317

X410

XXX071

X&xxxx;= 1

607-713-00-1

xxxxxxxxxxxx (XXX); xxxx-xxxxx-4-[({(X)-[(1,3-xxxxxxxx-5-xxxxxx-1X-xxxxxxx-4-xx)xxxxxxxx]xxxxx}xxx)xxxxxx]xxxxxxx

134098-61-6

Xxxxx Xxx. 3

Xxxxx Xxx. 2

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X301

X330

X317

X400

X410

XXX06 XXX09

Xxx

X301

X330

X317

X410

X&xxxx;= 100

X&xxxx;= 1&xxxx;000

607-714-00-7

xxxxxxxxxxxxxx-xxxxxx; methyl-2-({[4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]karbamoyl}sulfamoyl)-3-methylbenzoát

126535-15-7

Carc. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X400

X410

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 100

M = 10

607-715-00-2

xxxxxxxxx (XXX); isopropyl-2-(4-methoxybifenyl-3-yl)hydrazinkarboxylát

442-820-5

149877-41-8

STOT XX 2

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X373

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X373

X317

X410

X&xxxx;= 1

X&xxxx;= 1

613-319-00-0

xxxxxxxx

206-019-2

288-32-4

Xxxx. 1B

Acute Tox. 4

Xxxx Xxxx. 1X

X360X

X302

X314

XXX08

XXX07

XXX05

Xxx

X360X

X302

X314

613-320-00-6

xxxxxxx (XXX); 3-cyklohexyl-6,7-dihydro-1H-cyklopenta[d]pyrimidin-2,4(3H,5H)-dion

218-499-0

2164-08-1

Carc. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X400

X410

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 10

X&xxxx;= 10

616-213-00-2

xxxxxxxxxxxxx (XXX); 2-(4-xxxxxxxxxx)-X-{2-[3-xxxxxxx-4-(xxxx-2-xx-1-xxxxx)xxxxx]xxxxx}-2-(xxxx-2-xx-1-xxxxx)xxxxxxxx

374726-62-2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

X&xxxx;= 1

616-214-00-8

metosulam (ISO); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx

139528-85-1

Xxxx. 2

STOT XX 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X373 (xxx, xxxxxxx)

X400

X410

XXX08

XXX09

Xxx

X351

X373 (oči, xxxxxxx)

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100

616-215-00-3

dimethenamid-P (XXX); 2-xxxxx-X-(2,4-xxxxxxxx-3-xxxxxxx)-X-[(2X)-1-xxxxxxxxxxxxx-2-xx]xxxxxxxx

163515-14-8

Xxxxx Xxx. 4

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 10

X&xxxx;= 10

616-216-00-9

xxxxxxxxxx (XXX); X-(xxxxxxxxxxx)-4-(xxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx

158062-67-0

Xxxxx Tox. 4

X302

XXX07

Xxx

X302

616-217-00-4

xxxxxxxxxxx (XXX); [xxxxxx(xxx){1-[6-(xxxxxxxxxxxxxx)-3-xxxxxxx]xxxxx}-λ6-xxxxxxxxxxxx]xxxxxxxx

946578-00-3

Xxxxx Xxx. 4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X302

X400

X410

XXX07

XXX09

Xxx

X302

X410

X&xxxx;= 1

M = 1

2)

Xxxxxxx 3.2 xx xxxx xxxxx:

x)

Xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X a 613-149-00-7 xx xxxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxxxx limity

Poznámky k přípravkům

007-004-00-1

kyselina xxxxxxx&xxxx;…&xxxx;%

231-714-2

7697-37-2

X; R8

C; X35

X; X

X: 8-35

X: (1/2-)26-28- 36/37/39-45-63

X; R8: X ≥&xxxx;65 %

X; X35: X ≥ 20 %

C; X34: 5 % ≤ C &xx;&xxxx;20 %

X

015-003-00-2

xxxxxx xxxxxxxx; xxxxxxxxxx xxxxxxxx

215-142-0

1305-99-3

X; X15/29

X+; R26/28

Xn; X21

X32

Xx; R38-41

N; R50

F; X+; N

R: 15/29-21-26/28-32-38-41-50

S:(1/2-)26-28-30-36/37/39-43-45-60-61

N; X50: X ≥&xxxx;0,25 %

031-001-00-4

xxxxxxx xxxxx

215-114-8

1303-00-0

Xxxx. Xxx. 2; R60

Carc. Xxx. 2; X45

X; X48/23

X

X: 45-48/23-60

X: 45-53

E

050-008-00-3

tributylcíničité xxxxxxxxxx, x&xxxx;xxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxx xxxxxxx

Xxxx. Xxx. 2; X60-61

X; X25-48/23/25

Xx; R21

Xi; X36/38

X; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53-60-61

X: 45-53-60-61

X; R25: X ≥&xxxx;2,5 %

Xx; X22: 0,25 % ≤ X &xx;&xxxx;2,5 %

Xx: R21: X ≥&xxxx;1 %

T; X48/23/25: X ≥ 1 %

Xn; X48/20/22: 0,25 % ≤ X &xx;&xxxx;1 %

Xx; R36/38: X ≥&xxxx;1 %

X; R50-53: X ≥&xxxx;2,5 %

X; X51-53: 0,25 % ≤ C &xx;&xxxx;2,5 %

X52-53: 0,025 % ≤ C < 0,25 %

X

1

603-102-00-9

1,2-xxxxxxxxxx

203-438-2

106-88-7

X; X11

Xxxx. Cat. 3; R40

Xn; X20/21/22

Xx; X36/37/38

X; Xn

R: 11-20/21/22-36/37/38-40-

S: (2-)9-16-29-36/37-46

603-197-00-7

xxxxxxxxxxx (XXX); 1-(4-xxxxxxxxxx)-4,4-xxxxxxxx-3-(1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxx-3-xx

403-640-2

107534-96-3

Xxxx. Xxx. 3; X63

Xx; X22

X; X50-53

Xx; X

X: 22-50/53-63

X: (2-)22-36/37-60-61

N; R50-53: X ≥&xxxx;25 %

N; X51-53: 2,5 % ≤ X &xx;&xxxx;25 %

X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

606-054-00-7

xxxxxxxxxxx (XXX); 5-xxxxxxxxxxx-1,2-xxxxxx-4-xx-α, α,α-xxxxxxxx-2-xxxxx-x-xxxxxxxxxx

141112-29-0

Xxxx. Cat. 3; X63

X; X50-53

Xx; X

X: 50/53-63

X: (2-)36/37-60-61

N; X50-53: X ≥&xxxx;2,5 %

X; X51-53: 0,25 % ≤ C &xx;&xxxx;2,5 %

X52-53: 0,025 % ≤ C &xx;&xxxx;0,25 %

607-197-00-8

xxxxxxxx kyselina

203-931-2

112-05-0

Xi; R36/38

N; X51-53

Xx; X

X: 36/38-51/53

X: (2-)46-61

613-042-00-5

xxxxxxxx (ISO); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx

252-615-0

35554-44-0

Xxxx. Xxx. 3; R40

Xn; X20/22

Xx; R41

N; X51-53

Xx; X

X: 20/22-40-41-51/53

X: (2-)26-36/37/39-46-61

613-057-00-7

dodemorph (XXX); 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx

216-474-9

1593-77-7

Xxxx. Xxx. 3; X63

X; X34

X43

X; X50-53

X; X

X: 34-43-50/53-63

X: (1/2-)26-28-36/37/39-45-60-61

X; X34: X ≥&xxxx;10 %

Xi; X36/37/38: 5 % ≤ X &xx;&xxxx;10 %

X; X50-53: C ≥&xxxx;25 %

X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 %

R52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

613-133-00-X

xxxxxxxxxx (ISO); 5-xxxxxx-3-xxxxxxxxxxxxxx-1,2,4-xxxxxxxxxx

219-991-8

2593-15-9

Xxxx. Cat. 3; X40

Xx; X22

X43

X; X50-53

Xx; X

X: 22-40-43-50/53

X: (2-)36/37-46-60-61

X; X50-53: X ≥&xxxx;25 %

X; R51-53: 2,5 % ≤ C &xx;&xxxx;25 %

X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

613-149-00-7

xxxxxxxxx (XXX); 2-xxxx-xxxxx-5-[(4-xxxx-xxxxxxxxxxx)xxxxxxxx]-4-xxxxxxxxxxxxxx-3(2X)-xx

405-700-3

96489-71-3

X; X23/25

X; X50-53

X; X

X: 23/25-50/53

S: (1/2-)36/37-45-60-61

X; X50-53: X ≥ 0,025 %

X; X51-53: 0,0025 % ≤ X &xx;&xxxx;0,025 %

R52-53: 0,00025 % ≤ X &xx;&xxxx;0,0025 %

x)

Xxxxxxxxxxx položky xx vkládají x&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 3.2:

Indexové číslo

Mezinárodní xxxxxxxxxxxx chemických látek

Číslo XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxxxx xxxxxx

Xxxxxxxx x&xxxx;xxxxxxxxxx

019-003-00-3

xxxxxx-(X,X)-xxxx-2,4-xxxxxxx

246-376-1

24634-61-5

Xx; X36

Xx

X: 36

S: (2-)25-46

604-092-00-9

xxxxx, xxxxxxx-, rozvětvený [1];

xxxxx, 2-xxxxxxx-, rozvětvený;

fenol, 3-xxxxxxx-, xxxxxxxxxx;

xxxxx, 4-xxxxxxx-, xxxxxxxxxx;

xxxxx, (tetrapropenyl)deriváty [2]

310-154-3 [1]-[2]

121158-58-5 [1]

74499-35-7 [2]

C; X34

X; X50-53

X; X

X: 34-50/53

X: (1/2-)26-36/37/39-45-61

X; X50-53: X ≥&xxxx;2,5 %

X; X51-53: 0,25 % ≤ X < 2,5 %

R52-53: 0,025 % ≤ X &xx;&xxxx;0,25 %

606-148-00-8

xxxxxx (XXX);

2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx; [1]

D-karvon; (5X)-2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx; [2]

X-xxxxxx; (5X)-2-xxxxxx-5-(xxxx-1-xx-2-xx)xxxxxxxx-2-xx-1-xx [3]

202-759-5 [1]

218-827-2 [2]

229-352-5 [3]

99-49-0 [1]

2244-16-8 [2]

6485-40-1 [3]

X43

Xx

X: 43

X: (2-)24-37

606-149-00-3

xxxxxxxxxx (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx

335104-84-2

Xxxx. Xxx. 3; X63

Xx; X48/22

X43

X; R50-53

Xn; X

X: 43-48/22-50/53-63

X: (2-)36/37-46-60-61

X; X50-53: X ≥&xxxx;0,25 %

X; X51-53: 0,025 % ≤ C &xx;&xxxx;0,25 %

X52-53: 0,0025 % ≤ X &xx;&xxxx;0,025 %

607-707-00-9

xxxxxxxxxx-X-xxxxx (XXX); xxxxx-(2X)-2-{4-[(6-xxxxx-1,3-xxxxxxxxxx-2-xx)xxx]xxxxxx}xxxxxxxxx

71283-80-2

Xx; X48/22

X43

X; R50-53

Xn; X

X: 43-48/22-50/53

S: (2-)24-37-46-60-61

X; X50-53: X ≥&xxxx;25 %

X; X51-53: 2,5 % ≤ C &xx;&xxxx;25 %

X52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

607-708-00-4

xxxxxxxx kyselina

204-677-5

124-07-2

C; X34

X; X51-53

X; X

X: 34-51/53

X: (1/2-)26-36/37/39-45-61

607-709-00-X

dekanová kyselina

206-376-4

334-48-5

Xi; X36/38

X; X51-53

Xx; X

X: 36/38-51/53

X: (2-)25-46-61

607-710-00-5

1,2-benzendikarboxylová kyselina, xxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxx

271-093-5

68515-50-4

Xxxx. Xxx. 2; X60-61

X

X: 60-61

X: 53-45

607-711-00-0

xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx

203313-25-1

Xxxx. Xxx. 3; X62-63

Xx; X36/37

X43

X; X50-53

Xx; X

X: 36/37-43-50/53-62-63

X: (2-)36/37-60-61

Xi; X43: C ≥&xxxx;0,1 %

X; X50-53: C ≥&xxxx;25 %

X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 %

R52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

607-712-00-6

xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx

250-778-2

31717-87-0

Xxxx. Xxx. 3; X63

X; R34

R43

N; R51-53

C; X

X: 34-43-51/53-63

X: (1/2-)26-28-36/37/39-45-61

C; X34: C ≥ 10 %

Xx: R36/37/38: 5 % ≤ X &xx;&xxxx;10 %

607-713-00-1

fenpyroximát (XXX); xxxx-xxxxx-4-[({(X)-[(1,3-xxxxxxxx-5-xxxxxx-1X-xxxxxxx-4-xx)xxxxxxxx]xxxxx}xxx)xxxxxx]xxxxxxx

134098-61-6

X+; R26

Xn; R22

R43

N; X50-53

X+; N

R: 22-26-43-50/53

X: (1/2-)28-36/37-45-60-61-63

X; R50-53: X ≥&xxxx;0,25 %

X; R51-53: 0,025 % ≤ X < 0,25 %

X52-53: 0,0025 % ≤ X &xx;&xxxx;0,025 %

607-714-00-7

xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-({[4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)-3-xxxxxxxxxxxxx

126535-15-7

Xxxx. Cat. 3; X40

X; X50-53

Xx; X

X: 40-50/53

X: (2-)36/37-60-61

X; R50-53: X ≥&xxxx;0,25 %

X; X51-53: 0,025 % ≤ X < 0,25 %

X52-53: 0,0025 % ≤ X < 0,025 %

607-715-00-2

xxxxxxxxx (XXX); xxxxxxxxx-2-(4-xxxxxxxxxxxxxx-3-xx)xxxxxxxxxxxxxxxxxx

442-820-5

149877-41-8

X43

X; X50-53

Xx; N

R: 43-50/53

X: (2-)24-37-60-61

X; X50-53: X ≥&xxxx;25 %

X; R51-53: 2,5 % ≤ X &xx;&xxxx;25 %

R52-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

613-319-00-0

xxxxxxxx

206-019-2

288-32-4

Xxxx. Xxx 2; X61

Xx; X22

X; X34

X; C

R: 22-34-61

X: 53-45

613-320-00-6

xxxxxxx (ISO); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx

218-499-0

2164-08-1

Xxxx. Cat. 3; X40

X; R50-53

Xn; X

X: 40-50/53

X: (2-)36/37-60-61

X; R50-53: X ≥ 2,5 %

X; X51-53: 0,25 % ≤ C &xx;&xxxx;2,5 %

X52-53: 0,025 % ≤ X < 0,25 %

616-213-00-2

xxxxxxxxxxxxx (XXX); 2-(4-chlorfenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)fenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamid

374726-62-2

N; X50-53

X

X: 50/53

S: 60-61

X; X50-53: X ≥ 25 %

X; X51-53: 2,5 % ≤ X &xx;&xxxx;25 %

R52-53: 0,25 % ≤ C &xx;&xxxx;2,5 %

616-214-00-8

xxxxxxxxx (ISO); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx

139528-85-1

Xxxx. Xxx. 3; X40

Xx; X48/22

X; X50-53

Xx; X

X: 40-48/22-50/53

X: (2-)36/37-46-60-61

N; X50-53: X ≥ 0,025 %

X; X51-53: 0,0025 % ≤ X &xx;&xxxx;0,025 %

X52/53: 0,00025 % ≤ C &xx;&xxxx;0,0025 %

616-215-00-3

xxxxxxxxxxxx-X (XXX); 2-xxxxx-X-(2,4-xxxxxxxx-3-xxxxxxx)-X-[(2X)-1-xxxxxxxxxxxxx-2-xx]xxxxxxxx

163515-14-8

Xx; R22

R43

N; X50-53

Xx; X

X: 22-43-50/53

S: (2-)24-37-60-61

X; X50-53: X ≥&xxxx;2,5 %

X; X51-53: 0,25 % ≤ X &xx;&xxxx;2,5 %

R52-53: 0,025 % ≤ X &xx;&xxxx;0,25 %

616-216-00-9

xxxxxxxxxx (XXX); X-(xxxxxxxxxxx)-4-(xxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx

158062-67-0

Xx; R22

Xn

R: 22

S: (2-)46

616-217-00-4

xxxxxxxxxxx (ISO); [xxxxxx(xxx){1-[6-(xxxxxxxxxxxxxx)-3-xxxxxxx]xxxxx}-λ6-xxxxxxxxxxxx]xxxxxxxx

946578-00-3

Xx; X22

X; R50-53

Xn; X

X: 22-50/53

X: (2-)60-61

N; X50-53: X ≥ 25 %

N; X51-53: 2,5 % ≤ X &xx;&xxxx;25 %

X52-53: 0,25 % ≤ C &xx;&xxxx;2,5 %